Home > Insider Trading > Filing (0001209191-21-055492)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1087294	Cumberland Pharmaceuticals Inc	CPIX	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1684087	Caroline Young	2525 West End Avenue Suite 950 Nashville TN 37203		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2021-07-01	15	$2.91	12,743	No	4	P	Direct
Common Stock	Acquisiton	2021-07-02	15	$2.94	12,758	No	4	P	Direct
Common Stock	Acquisiton	2021-07-06	15	$3.14	12,773	No	4	P	Direct
Common Stock	Acquisiton	2021-07-07	15	$3.21	12,788	No	4	P	Direct
Common Stock	Acquisiton	2021-07-08	15	$3.18	12,803	No	4	P	Direct
Common Stock	Acquisiton	2021-07-09	15	$3.13	12,818	No	4	P	Direct
Common Stock	Acquisiton	2021-07-12	15	$3.33	12,833	No	4	P	Direct
Common Stock	Acquisiton	2021-07-13	15	$3.48	12,848	No	4	P	Direct
Common Stock	Acquisiton	2021-07-14	15	$3.33	12,863	No	4	P	Direct
Common Stock	Acquisiton	2021-07-15	15	$3.27	12,878	No	4	P	Direct
Common Stock	Acquisiton	2021-07-16	15	$3.28	12,893	No	4	P	Direct
Common Stock	Acquisiton	2021-07-19	15	$3.23	12,908	No	4	P	Direct
Common Stock	Acquisiton	2021-07-20	15	$3.24	12,923	No	4	P	Direct
Common Stock	Acquisiton	2021-07-21	15	$3.26	12,938	No	4	P	Direct
Common Stock	Acquisiton	2021-07-22	15	$3.36	12,953	No	4	P	Direct
Common Stock	Acquisiton	2021-07-23	15	$3.35	12,968	No	4	P	Direct
Common Stock	Acquisiton	2021-07-26	15	$3.41	12,983	No	4	P	Direct
Common Stock	Acquisiton	2021-07-27	15	$3.39	12,998	No	4	P	Direct
Common Stock	Acquisiton	2021-07-28	15	$3.42	13,013	No	4	P	Direct
Common Stock	Acquisiton	2021-07-29	15	$3.42	13,028	No	4	P	Direct
Common Stock	Acquisiton	2021-07-30	15	$3.31	13,043	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct

Footnotes

The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.